Amrutanjan Health Care informs about quarterly statement of investor complaints

08 Apr 2017 Evaluate

Amrutanjan Health Care has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2017, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Amrutanjan Healthcar Share Price

674.10 -7.15 (-1.05%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×